International Journal of Dermatology
SCImago
Q1
WOS
Q1
Impact factor
3.5
SJR
0.771
CiteScore
4.7
Categories
Dermatology
Areas
Medicine
Years of issue
1963-2025
journal names
International Journal of Dermatology
INT J DERMATOL
Top-3 citing journals

International Journal of Dermatology
(9112 citations)

Journal of the American Academy of Dermatology
(6623 citations)

Journal of the European Academy of Dermatology and Venereology
(4285 citations)
Top-3 organizations

Mayo Clinic
(251 publications)
Istituti di Ricovero e Cura a Carattere Scientifico
(187 publications)

University of Miami
(149 publications)
Istituti di Ricovero e Cura a Carattere Scientifico
(102 publications)

Mayo Clinic
(82 publications)

Post graduate Institute of Medical Education and Research
(41 publications)
Most cited in 5 years
Found
Publications found: 2252
Q3

Role and Responsibilities of Various Stakeholders in Pharmacovigilance (PV)
Phougat P., Beniwal M., Kapoor G., Aggarwal N., Kumari A., Sharma R., Chopra H., Sharma R., Kamal M.A.
Abstract::
In this review paper, we have analyzed the potential and issues associated with Pharmacovigilance
(PV). The analysis is divided into four sections: background, stakeholders, data sources,
and medicinal chemistry. Each section discusses the current state, the future trends, and the best practices
of Pharmacovigilance (PV). The main purpose, methods, results, and implications of our analysis
are summarized.
Background::
Pharmacovigilance (PV) is the science and practice of monitoring, evaluating, understanding,
and preventing adverse drug reactions. Pharmacovigilance (PV) was established by the World
Health Organization in response to the thalidomide tragedy of 1961. The main purpose of Pharmacovigilance
(PV) is to ensure the safety and efficacy of drugs in clinical practice.
Stakeholders::
Pharmacovigilance (PV) involves various stakeholders, such as patients, pharmacists,
pharmaceutical companies, healthcare professionals, and regulatory authorities. Each stakeholder has
a different role and responsibility in reporting, processing, analyzing, and communicating information
about adverse drug reactions. Patient engagement is a key factor for enhancing Pharmacovigilance
(PV) practices.
Data Sources::
Pharmacovigilance (PV) relies on data from various sources, such as clinical trials,
spontaneous reports, electronic medical records, biomedical literature, and patient-reported data in
online health forums. These data sources can provide valuable insights into the real-world use and
safety of drugs, as well as the preferences and needs of patients. However, these data sources also
pose challenges in terms of quality, validity, reliability, and accessibility.
Medicinal Chemistry::
Medicinal chemistry is the branch of chemistry that deals with the design, synthesis,
and evaluation of new drugs and their biological effects. Medicinal chemistry can enhance Pharmacovigilance
(PV) practices by finding new therapeutic indications for existing drugs or compounds that have already
been tested for safety and efficacy. Medicinal chemistry also requires careful design and evaluation of
covalent inhibitors, bi-substrate inhibitors, stabilizers of protein non-effective conformations, and hydrophobic
pocket modifiers to ensure their safety and efficacy.
Implications::
Pharmacovigilance (PV) is a dynamic and evolving discipline that requires collaboration,
regulation, education, and innovation to improve patient safety and care. This review aims to
provide a comprehensive overview of the potential and issues associated with Pharmacovigilance
(PV) practices.
Q2

A Comprehensive Review on Nanoparticles as Drug Delivery System and Their Role for Management of Hypertension
Prerna, Bhatt D.C., Mir K.B., Kumar V., Rathor S.
<p>The current global epidemic of hypertension is not a disease in and of itself but rather
a significant risk factor for serious cardiovascular conditions such as peripheral artery disease,
heart failure, myocardial infarction, and stroke. Although many medications that work through
various mechanisms of action are available on the market in conventional formulations to treat
hypertension, these medications face significant difficulties with their bioavailability, dosing,
and associated side effects, which significantly reduces the effectiveness of their therapeutic
interventions. Numerous studies have shown that nanocarriers and nanoformulations can minimize
the toxicity associated with high doses of the drug while greatly increasing the drug's bioavailability
and reducing the frequency of dosing.
</p>
<p>
This review sheds light on the difficulties posed by traditional antihypertensive formulations and
highlights the necessity of oral nanoparticulate systems to solve these issues. Because hypertension
has a circadian blood pressure pattern, chronotherapeutics can be very important in treating
the condition. On the other hand, nanoparticulate systems can be very important in managing
hypertension.</p>
Q3

Feasting on the Future: Unveiling Edible Insects as a Sustainable Food with Enriched Health Benefits
Kumar A., Goyal N., Pramanik J., Joia S., Singh S., Prajapati B.G.
Abstract:
Animal- and plant-based foods are considered staple foods worldwide. As the population increases, new alternative foods with higher nutritional value and sustainable nature are needed. Moreover, the current food system drastically impacts the environment and may result in unsustainability. The livestock sector significantly contributes to greenhouse gas emissions and is a
major user of land and water resources. Additionally, excessive animal farming adversely affects
the environment, accelerating climate change. To solve these problems, alternative and eco-friendly food resources that offer proper nutritional and health benefits are needed. Although edible insects have been used through several civilizations, they have emerged as an exciting and promising approach. Edible insects can transform various organic products into high-quality proteins
with essential amino acids, including agricultural and food waste products. Edible insects are nutritionally rich and contain healthy fatty acids such as lauric acid, oleic acid, and omega 3 and 6. In
addition, edible insect production requires much less resources, such as water and land, and emits
significantly less greenhouse gases, thus contributing to sustainable food production. This review
provides a comprehensive understanding of the nutritional profile, sustainability aspects, and
health benefits of edible insects.
Q3

Comparative Evaluation of Cefixime Microspheres Utilizing a Natural Polymer and a Synthetic Polymer
Arora D., Taneja Y., Sharma A., Sharma P., Jatin, Guarve K., Rani N., Verma I.
Background::
Microspheres are naturally biodegradable, free-flowing powders with a particle
size of less than 200 micrometres that are comprised of proteins or synthetic polymers. Using
microspheres is a reliable strategy to ensure that the drug is accurately delivered to the target area and
that the right concentration is kept there without having any unfavourable side effects.
Objective::
The objective of the present study was to create a sustained-release cefixime trihydrate
microsphere delivery system employing natural and synthetic polymers as a carrier and increase therapeutic
effectiveness.
Methods::
Due to the simplicity of processing, the solvent injection method was used to create microspheres.
Microspheres were created with this technology using the sustained-release polymer, sodium
alginate, and active material (drug). The compatibility of components with the drug was evaluated
using XRD and FT-IR. In an in-vitro release research, the dissolving medium was phosphate buffer
at pH 6.8. For the kinetic analysis of the drug release mechanism, graphs for zero-order, first-order,
Higuchi's, Korsmeyer-Peppas, and Hixson-Crowell models were also created.
Results::
The best formulation was chosen from the batches, and in-vitro cefixime trihydrate release
studies for various microspheres containing cefixime trihydrate in phosphate buffer (pH 7.4) for 8
hours were performed. The dissolution profiles of formulations F4 and F8 showed that the formulation,
including xanthan gum, F8, released 55.01% more medication in 8 hours than the formulation
using HPMC, F4. X-ray diffraction, swelling index of drug-laden microspheres, and Scanning Electron
Microscopy were used to evaluate formulation F8. The graphs for zero-order, first-order, Higuchi's,
Korsmeyer-Peppas, and Hixson- Crowell models were plotted, and the optimised batch was
discovered to match Higuchi's drug release kinetics with an R2 value of 0.990.
Conclusion::
Cefixime trihydrate microspheres can be utilized as a new drug delivery technology to
minimize dose frequency and, as a result, to promote patient compliance.
Q2

Anticancer Potential of Pineapple and its Bioactive Compound Bromelain
Kumar D., Suchitra, Mundlia J., Yadav S.K., Yadav D., Aggarwal N., Chopra H., Kumar V., Kamal M.A.
Abstract:
Various ailments have been treated with pineapple [Ananas comosus (L.) Merr.] throughout medicinal
history. Pineapple and its bioactive compound bromelain possess health-promoting benefits. Detailed information
on the chemotherapeutic activities of pineapple and its bioactive compound bromelain is provided
in this review, which analyses the current literature regarding their therapeutic potential in cancer. Research
on disease models in cell cultures is the focus of much of the existing research. Several studies have demonstrated
the benefits of pineapple extract and bromelain for in vitro and in vivo cancer models. Preliminary animal
model results show promise, but they must be translated into the clinical setting. Research on these compounds
represents a promising future direction and may be well-tolerated.
Q3

Anti-inflammatory and Anti-arthritic Properties of Mucuna gigantea Plant Extracts: Establishing by Molecular Docking Study
kumar S., Srivastava P., Mujwar S., Gauttam V., Gupta S.
Background:
Mucuna giganteais a traditional plant reported in the management of nervous disorders, male infertility, etc., and also exhibits aphrodisiac, anti-oxidant, and anti-diabetic properties. Very few studies are conducted on Mucuna gigantea. It has not been pharmacologically evaluated for rheumatoid arthritis (RA). In RA, the body's natural defence mechanism gets confused and begins to target the healthy tissues in the body, which leads to joint pain, swelling, bone erosion, and joint stiffness. It is a condition that is classified as an auto-immune disorder.
Methods:
In-silico docking depicted that beta-sitosterol is present in Mucuna gigantea out of ligand library prepared based on a literature survey using computational analysis. Inflammation was induced by carrageen and chronic inflammation was induced by Freund’s complete adjuvant in the plantar surface of the rats. The petroleum ether, ethanolic and aqueous extracts in three divided doses (75, 150, and 300 mg/kg) were administered orally. Diclofenac sodium (10 mg/kg), prednisolone (5 mg/kg), and methotrexate (0.5 mg/kg) were used as standard. The statistical significance between means was analyzed using one-way ANOVA, followed by Dunnett’s multiple range test. The values are expressed as mean ± SD for each group
(n=6), and aP<0.0001, bP<0.001, and cP<0.05 were compared with a negative control group.
Results:
Ethanolic and petroleum ether extracts showed a statistically significant aP<0.0001 effect at 3hr with 300mg/kg effect in
analgesic activity, whereas aqueous extracts showed statistically significant aP<0.0001 effect at 1.5hr with 150 and 300mg/kg. In the
carrageen-induced model, all three extracts at 300 mg/kg showed a statistically significant aP<0.0001 effect from 2- 4hr. In Freund’s
adjuvant model, all three extracts at all doses showed a statistically significant aP<0.0001 effect. Also, Mucuna gigantea remarkably
ameliorated altered WBCs, rheumatoid factor, and positively modified radiographic and histopathological changes.
Conclusion:
Taken together, these results support the traditional use of Mucuna gigantea as a potent anti-inflammatory and anti-arthritic
agent that may be proposed for rheumatoid arthritis treatment.
Q3

A Concise Review on Magnetic Nanoparticles: Their Properties, Types, Synthetic Methods, and Current Trending Applications
M. M., R. B., Kumar S.K., R. S.K.
Abstract:
In recent years, there has been significant research on developing magnetic nanoparticles (MNPs) with multifunctional characteristics. This review focuses on the properties and various types of MNPs, methods of their synthesis, and biomedical, clinical, and other applications.
These syntheses of MNPs were achieved by various methods, like precipitation, thermal, pyrolysis, vapor deposition, and sonochemical. MNPs are nano-sized materials with diameters ranging
from 1 to 100 nm. The MNPs have been used for various applications in biomedical, cancer
theranostic, imaging, drug delivery, biosensing, environment, and agriculture. MNPs have been
extensively researched for molecular diagnosis, treatment, and therapeutic outcome monitoring
in a range of illnesses. They are perfect for biological applications, including cancer therapy,
thrombolysis, and molecular imaging, because of their nanoscale size, surface area, and absence
of side effects. In particular, MNPs can be used to conjugate chemotherapeutic medicines (or)
target ligands/proteins, making them beneficial for drug delivery. However, up until that time,
some ongoing issues and developments in MNPs include toxicity and biocompatibility, targeting
accuracy, regulation and safety, clinical translation, hyperthermia therapy, immunomodulatory
effects, multifunctionality, and nanoparticle aggregation.
Q2

Serum Gamma Glutamyl Transferase: Understanding its Contribution as a Potential Predictor of the Occurrence of Type 2 Diabetes
Anupam S., Goel S., Bhatti K., Mehta D.K., Das R.
Introduction:
The liver and kidneys are the primary locations of the glutathione metabolism enzyme gamma-glutamyl transferase (GGT). The two main factors contributing to an
increase are hepatic illnesses and excessive alcohol use. This study set out to test a theory on the
predictive importance of the association between GGT and Type 2 diabetes mellitus. (T2DM).
Methods:
In order to do this, we combed through PubMed, Google Scholar, Medline, and Science Direct for a wide range of information from previous studies. Attributes were established at
the outset and compared to GGT concentration.
Result:
GGT, present in most cells, absorbs glutathione for intracellular antioxidant defences.
This study links GGT to hepatic enzymes including HDL, LDL, and triglyceride. LDL, triglycerides, AST, and ALT increased with GGT concentration, but LDL decreased. Because of obesity,
GGT production rises with BMI. We found that greater GGT levels were associated with more
T2DM after analysing data from multiple sources.
Conclusion:
This literature review concludes that GGT is related to other factors such as BMI,
HDL, AST, and triglycerides in the development of diabetes mellitus. Serum GGT was found to
be a potential predictor of metabolic syndrome and T2DM
Q2

Evaluation of Moringa Oleifera Leaf Extract for its In vitro Antibacterial Properties, Mechanism of Action, and In vivo Corneal Ulcer Healing Effects in Rabbits’ Eyes
Bibi A., dhanawat M., Aman S., Chauhan S., Chalotra R., Mujwar S., Kaur N., Maivagna C., Gupta S.
Background:
M. oleifera is the most adapted tree species in different medicinal eco-systems
and has resilience against climate changes. This multiple-use tree provides healthy foods,
snacks, honey, and fuel. Besides this, it has immense promising applications by offering antimicrobial
and antibacterial activities for targeted uses. This validates the court of Hippocrates that let
food be the medicine and medicine be the food for which moringa qualifies.
Objective:
The objective of this study is to assess the antioxidant properties of M. oleifera, in
vitro antibacterial activity of hydro-ethanolic extract, and further investigate in vivo healing potential
of M. oleifera for corneal ulcers and in silico analysis.
Methods:
To evaluate the antioxidant and in vitro antibacterial potency of the hydro-ethanolic extract
of M. oleifera on clinically isolated multidrug-resistant strains of Staphylococcus aureus using
agar well diffusion assay. Furthermore, in vivo, healing response of M. oleifera extract was
analysed on corneal ulcers induced in rabbit eyes infected with methicillin-resistant Staphylococcus
aureus.
Results:
The M. oleifera extract exhibited exponential antioxidant activity. In-vitro antibacterial
activity was evaluated by agar well diffusion assay showing zone of inhibition ranging from 11.05
± 0.36 to 20 ± 0.40 mm at concentrations of 20, 40, 80, and 160 mg/ml, whereas, in our finding,
no zone of inhibition was observed below 20 mg/ml concentration, which indicated that there is
threshold limit below which the antibacterial activity of M. oleifera extract is not observed. Furthermore,
continuous application of 3% and 5% M. oleifera extract (eye drop) four times a day for
14 consecutive days showed a significant healing response of the eyes of rabbits with corneal ulcers.
Conclusion:
These results suggest that M. oleifera extract could be a viable alternative or in combination
could be used in existing antibacterial therapies for corneal ulcers. Additionally, there is a
possibility of commercial formulation of M. oleifera extract in the form of deliverable pharmaceutical
products; therefore, it should be explored further.
Q2

The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
dhanawat M., Malik G., Wilson K., Gupta S., Gupta N., Sardana S.
Abstract:
Dr. Aloysius Alzheimer, a German neuropathologist and psychiatrist, recognized the
primary instance of Alzheimer's disease (AD) for a millennium, and this ailment, along with its related
dementias, remains a severe overall community issue related to health. Nearly fifty million individuals
worldwide suffer from dementia, with Alzheimer's illness contributing to between 60 and
70% of the instances, estimated through the World Health Organization. In addition, 82 million individuals
are anticipated to be affected by the global dementia epidemic by 2030 and 152 million by
2050. Furthermore, age, environmental circumstances, and inherited variables all increase the likelihood
of acquiring neurodegenerative illnesses. Most recent pharmacological treatments are found in
original hypotheses of disease, which include cholinergic (drugs that show affective cholinergic system
availability) as well as amyloid-accumulation (a single drug is an antagonist receptor of Nmethyl
D-aspartate). In 2020, the FDA provided approval on anti-amyloid drugs. According to
mounting scientific data, this gut microbiota affects healthy physiological homeostasis and has a
role in the etiology of conditions that range between obesity and neurodegenerative disorders like
Alzheimer's. The microbiota-gut-brain axis might facilitate interconnection among gut microbes as
well as the central nervous system (CNS). Interaction among the microbiota-gut system as well as
the brain occurs through the “two-way” microbiota-gut-brain axis. Along this axis, the stomach as
well as the brain develop physiologically and take on their final forms. This contact is constant and
is mediated by numerous microbiota-derived products. The gut microbiota, for instance, can act as
non-genetic markers to set a threshold for maintaining homeostasis or getting ill. The scientific
community has conducted research and found that bowel dysbiosis and gastrointestinal tract dysregulation
frequently occur in Alzheimer's disease (AD) patients. In this review, the effects of the microbiota-
gut-brain axis on AD pathogenesis will be discussed.
Q2

Bioactive Milk Peptides as a Nutraceutical Opportunity and Challenges
Kapoor D.U., Gaur M., Kumar A., Ansari M.N., Prajapati B.
Abstract:
The biotechnology field has witnessed rapid advancements, leading to the development
of numerous proteins and peptides (PPs) for disease management. The production and isolation of
bioactive milk peptides (BAPs) involve enzymatic hydrolysis and fermentation, followed by purification
through various techniques such as ultrafiltration and chromatography. The nutraceutical
potential of bioactive milk peptides has gained significant attention in nutritional research, as these
peptides may regulate blood sugar levels, mitigate oxidative stress, improve cardiovascular
health, gut health, bone health, and immune responses, and exhibit anticancer properties. However,
to enhance BAP bioavailability, the encapsulation method can be used to offer protection
against protease degradation and controlled release. This article provides insights into the composition,
types, production, isolation, bioavailability, and health benefits of BAPs.
Q3

A recent update on Ayurvedic anti-asthmatic formulations: Highlighting the role of major anti-asthmatic plants
Chaudhary J., Bhatia M., Jain A., Sonam, Dhingra A., Chopra B.
Abstract:
Asthma is a chronic heterogeneous airway obstruction disorder defined by a complex cascade of pathophysiological conditions that lead to recurring bronchial hyper-responsiveness and underlying inflammation, lowering the patient’s quality of life. Despite the availability of various synthetic medications for the management of asthma, it has become one of the leading causes of death worldwide. Furthermore, the present allopathic treatment possesses severe long-term negative effects, which make people more attracted to the safer and easily available indigenous traditional and Ayurvedic system of medicine. Ayurveda is regarded as the “Mother of all healing” and “Science of Life,” which treats all the ailments, including asthma, by restoring a balance between three main components of the body- Vata, Pitta, and Dosha. Various clinically effective and less toxic anti-asthmatic Ayurvedic herbal preparations are available for the management of asthma and related complications which act by causing mast cell deactivation, inhibition of Th1, Th2, Th7 response, T-cell suppression, etc., therefore, efforts have been made to compile all the relevant literature related to the ayurvedic anti-asthmatic formulations and scrutinize the efficacy of selected plants present in the majority in those formulations in asthma along with the structure and mode of action of phytoconstituent responsible for designing novel molecules with better efficacy. Research on these selected plants can also have economic significance as various constituents isolated from these plants for their anti-asthmatic effect can further be explored to discover their potential in medicinal, diagnostic and cosmetic field.
Q2

Convection-enhanced Diffusion: A Novel Tactics to Crack the BBB
Dhanawat M., Garima, Wilson K., Gupta S., Chalotra R., Gupta N.
Abstract:
Although the brain is very accessible to nutrition and oxygen, it can be difficult to deliver
medications to malignant brain tumours. To get around some of these issues and enable the use of
therapeutic pharmacological substances that wouldn't typically cross the blood-brain barrier (BBB),
convection-enhanced delivery (CED) has been developed. It is a cutting-edge strategy that gets beyond
the blood-brain barrier and enables targeted drug administration to treat different neurological
conditions such as brain tumours, Parkinson's disease, and epilepsy. Utilizing pressure gradients to
spread the medicine across the target area is the main idea behind this diffusion mechanism. Through
one to several catheters positioned stereotactically directly within the tumour mass, around the tumour,
or in the cavity created by the resection, drugs are given. This method can be used in a variety
of drug classes, including traditional chemotherapeutics and cutting-edge investigational targeted
medications by using positive-pressure techniques. The drug delivery volume must be optimized for
an effective infusion while minimizing backflow, which causes side effects and lowers therapeutic
efficacy. Therefore, this technique provides a promising approach for treating disorders of the central
nervous system (CNS).
Q3

The Fascinating Effects of Flavonoids on Lung Cancer: A Review
Singh D., dhanawat M., Verma I., Gupta S.
Abstract:
Lung cancer has emerged as one of the most often reported illnesses and leading
causes of mortality worldwide. Inefficient, lack of safety, low therapeutic index, unpleasant effects,
and excessive cost have led to a loss of trust in synthetic medications, limiting their use.
Natural compounds have good anticancer potential without unwanted toxic effects. Among
them, flavonoids are the most important compounds. Flavonoids are polyphenolic chemical
compounds abundant in fruits and vegetables and are essential in preventing lung cancer. Their
potent anticancer effects are said to be based on a wide range of biological actions, such as antioxidants,
anti-mutagenesis, anti-inflammation, and differentiation induction, preventing cancer
cell proliferation through regulating signal transduction pathways, triggering cell cycle arrest,
and activating apoptosis or autophagy; anti-invasion; anti-metastasis, altering cancer cell
drug resistance and increasing sensitization to chemotherapy. This review illustrates the most
recent advancements in flavonoids in lung cancer and their associated molecular mechanisms
using information from scientific research studies like in vitro and in vivo clinical trials. It
takes these data into theory and practice.
Q2

An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery
Kumar V., Garg V., Saini N., Aggarwal N., Kumar H., Kumar D., Chopra H., Kamal M.A., Dureja H.
Background:
A nanoemulsion is a colloidal system of small droplets dispersed in
another liquid. It has attracted considerable attention due to its unique properties and various
applications. Throughout this review, we provide an overview of nanoemulsions and how they
can be applied to various applications such as drug delivery, food applications, and pesticide
formulations.
Objective:
This updated review aims to comprehensively overview nanoemulsions and their
applications as a versatile platform for drug delivery, food applications, and pesticide formulations.
Methods:
Research relevant scientific literature across various databases, including PubMed,
Scopus, and Web of Science. Suitable keywords for this purpose include "nanoemulsion," "drug
delivery," and "food applications." Ensure the search criteria include recent publications to ensure
current knowledge is included.
Results:
Several benefits have been demonstrated in the delivery of drugs using nanoemulsions,
including improved solubility, increased bioavailability, and controlled delivery. Nanoemulsions
have improved some bioactive compounds in food applications, including vitamins and antioxidants.
At the same time, pesticide formulations based on nanoemulsions have also improved
solubility, shelf life, and effectiveness.
Conclusion:
The versatility of nanoemulsions makes them ideal for drug delivery, food, and
pesticide formulation applications. These products are highly soluble, bioavailable, and targeted,
providing significant advantages. More research and development are required to implement
nanoemulsion-based products on a commercial scale.
Top-100
Citing journals
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
|
|
International Journal of Dermatology
9112 citations, 4.75%
|
|
Journal of the American Academy of Dermatology
6623 citations, 3.45%
|
|
Journal of the European Academy of Dermatology and Venereology
4285 citations, 2.23%
|
|
British Journal of Dermatology
3826 citations, 1.99%
|
|
Actas Dermo-Sifiliograficas
2651 citations, 1.38%
|
|
Clinics in Dermatology
2607 citations, 1.36%
|
|
Journal of Dermatology
2169 citations, 1.13%
|
|
Dermatologic Clinics
2003 citations, 1.04%
|
|
Clinical and Experimental Dermatology
1895 citations, 0.99%
|
|
Pediatric Dermatology
1870 citations, 0.97%
|
|
Dermatologic Therapy
1696 citations, 0.88%
|
|
American Journal of Clinical Dermatology
1650 citations, 0.86%
|
|
Anais Brasileiros de Dermatologia
1618 citations, 0.84%
|
|
Dermatologic Surgery
1583 citations, 0.83%
|
|
American Journal of Dermatopathology
1455 citations, 0.76%
|
|
Journal of Cutaneous Pathology
1362 citations, 0.71%
|
|
Journal of Dermatological Treatment
1347 citations, 0.7%
|
|
Piel
1340 citations, 0.7%
|
|
Journal of Cosmetic Dermatology
1302 citations, 0.68%
|
|
JDDG - Journal of the German Society of Dermatology
1260 citations, 0.66%
|
|
Annales de Dermatologie et de Venereologie
1056 citations, 0.55%
|
|
Journal of Investigative Dermatology
1017 citations, 0.53%
|
|
Archives of Dermatological Research
1016 citations, 0.53%
|
|
Journal of Cutaneous Medicine and Surgery
1004 citations, 0.52%
|
|
Australasian Journal of Dermatology
980 citations, 0.51%
|
|
Cureus
974 citations, 0.51%
|
|
Mycoses
850 citations, 0.44%
|
|
Dermatology
774 citations, 0.4%
|
|
International Journal of Molecular Sciences
769 citations, 0.4%
|
|
Experimental Dermatology
679 citations, 0.35%
|
|
Dermatology and Therapy
658 citations, 0.34%
|
|
Frontiers in Immunology
656 citations, 0.34%
|
|
Annals of Dermatology
614 citations, 0.32%
|
|
Hautarzt
609 citations, 0.32%
|
|
PLoS ONE
608 citations, 0.32%
|
|
JAAD Case Reports
601 citations, 0.31%
|
|
Contact Dermatitis
592 citations, 0.31%
|
|
Journal of Clinical Medicine
580 citations, 0.3%
|
|
Frontiers in Medicine
555 citations, 0.29%
|
|
Clinical, Cosmetic and Investigational Dermatology
524 citations, 0.27%
|
|
EMC - Dermatologie
507 citations, 0.26%
|
|
Cochrane Database of Systematic Reviews
504 citations, 0.26%
|
|
Mycopathologia
451 citations, 0.24%
|
|
PLoS Neglected Tropical Diseases
436 citations, 0.23%
|
|
Scientific Reports
412 citations, 0.21%
|
|
Expert Review of Dermatology
410 citations, 0.21%
|
|
JAMA Dermatology
381 citations, 0.2%
|
|
Medical Mycology
378 citations, 0.2%
|
|
BMJ Case Reports
375 citations, 0.2%
|
|
Photodermatology Photoimmunology and Photomedicine
364 citations, 0.19%
|
|
Indian Journal of Dermatology, Venereology and Leprology
359 citations, 0.19%
|
|
International Journal of Women's Dermatology
356 citations, 0.19%
|
|
Skin Appendage Disorders
353 citations, 0.18%
|
|
Anais Brasileiros de Dermatologia (Versão em Português)
346 citations, 0.18%
|
|
EMC - Dermatología
335 citations, 0.17%
|
|
Medicine (United States)
333 citations, 0.17%
|
|
Skin Research and Technology
331 citations, 0.17%
|
|
Indian Dermatology Online Journal
317 citations, 0.17%
|
|
Current Dermatology Reports
297 citations, 0.15%
|
|
Journal of Dermatological Science
296 citations, 0.15%
|
|
Expert Opinion on Pharmacotherapy
295 citations, 0.15%
|
|
Reactions Weekly
289 citations, 0.15%
|
|
Vestnik dermatologii i venerologii
287 citations, 0.15%
|
|
Nishinihon Journal of Dermatology
269 citations, 0.14%
|
|
Clinical Case Reports
267 citations, 0.14%
|
|
International Journal of Cosmetic Science
258 citations, 0.13%
|
|
Dermatitis
257 citations, 0.13%
|
|
Cancers
257 citations, 0.13%
|
|
Autoimmunity Reviews
249 citations, 0.13%
|
|
Dermatologica Sinica
244 citations, 0.13%
|
|
Journal of Fungi
244 citations, 0.13%
|
|
Side Effects of Drugs Annual
234 citations, 0.12%
|
|
Seminars in Cutaneous Medicine and Surgery
220 citations, 0.11%
|
|
Oral Diseases
216 citations, 0.11%
|
|
Clinical Reviews in Allergy and Immunology
214 citations, 0.11%
|
|
Indian Journal of Dermatology
208 citations, 0.11%
|
|
Clinical Infectious Diseases
207 citations, 0.11%
|
|
Journal of Cosmetic and Laser Therapy
204 citations, 0.11%
|
|
Case Reports in Dermatology
202 citations, 0.11%
|
|
Molecules
201 citations, 0.1%
|
|
International Wound Journal
200 citations, 0.1%
|
|
Allergy: European Journal of Allergy and Clinical Immunology
200 citations, 0.1%
|
|
Archives of Dermatology
200 citations, 0.1%
|
|
Transactions of the Royal Society of Tropical Medicine and Hygiene
199 citations, 0.1%
|
|
Journal of Allergy and Clinical Immunology
197 citations, 0.1%
|
|
International Journal of Environmental Research and Public Health
191 citations, 0.1%
|
|
Plastic and Reconstructive Surgery
189 citations, 0.1%
|
|
Aktuelle Dermatologie
186 citations, 0.1%
|
|
New England Journal of Medicine
186 citations, 0.1%
|
|
Lupus
186 citations, 0.1%
|
|
Revue de Medecine Interne
185 citations, 0.1%
|
|
Clinical Rheumatology
185 citations, 0.1%
|
|
Skinmed
185 citations, 0.1%
|
|
American Journal of Tropical Medicine and Hygiene
177 citations, 0.09%
|
|
Journal of wound care
175 citations, 0.09%
|
|
Biomedicines
174 citations, 0.09%
|
|
Cutaneous and Ocular Toxicology
173 citations, 0.09%
|
|
Cosmetics
173 citations, 0.09%
|
|
Dermatology Research and Practice
170 citations, 0.09%
|
|
Clinical Microbiology Reviews
169 citations, 0.09%
|
|
Show all (70 more) | |
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
|
Citing publishers
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
|
|
Elsevier
47630 citations, 24.82%
|
|
Wiley
44864 citations, 23.38%
|
|
Springer Nature
18224 citations, 9.5%
|
|
Ovid Technologies (Wolters Kluwer Health)
8266 citations, 4.31%
|
|
Taylor & Francis
7274 citations, 3.79%
|
|
MDPI
5638 citations, 2.94%
|
|
SAGE
3827 citations, 1.99%
|
|
Frontiers Media S.A.
2406 citations, 1.25%
|
|
Oxford University Press
2345 citations, 1.22%
|
|
S. Karger AG
1988 citations, 1.04%
|
|
Hindawi Limited
1492 citations, 0.78%
|
|
BMJ
1174 citations, 0.61%
|
|
Public Library of Science (PLoS)
1149 citations, 0.6%
|
|
Georg Thieme Verlag KG
834 citations, 0.43%
|
|
American Medical Association (AMA)
811 citations, 0.42%
|
|
Medknow
788 citations, 0.41%
|
|
Mary Ann Liebert
597 citations, 0.31%
|
|
American Society for Microbiology
593 citations, 0.31%
|
|
Scientific Scholar
509 citations, 0.27%
|
|
Bentham Science Publishers Ltd.
479 citations, 0.25%
|
|
Cambridge University Press
404 citations, 0.21%
|
|
Mark Allen Group
394 citations, 0.21%
|
|
Spandidos Publications
370 citations, 0.19%
|
|
American Chemical Society (ACS)
353 citations, 0.18%
|
|
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
342 citations, 0.18%
|
|
331 citations, 0.17%
|
|
290 citations, 0.15%
|
|
Kyushu University
264 citations, 0.14%
|
|
American Academy of Pediatrics
244 citations, 0.13%
|
|
Media Sphere Publishing House
242 citations, 0.13%
|
|
XMLink
231 citations, 0.12%
|
|
IntechOpen
230 citations, 0.12%
|
|
Korean Dermatological Association and The Korean Society for Investigative Dermatology
224 citations, 0.12%
|
|
Cold Spring Harbor Laboratory
223 citations, 0.12%
|
|
Walter de Gruyter
218 citations, 0.11%
|
|
Baishideng Publishing Group
211 citations, 0.11%
|
|
Le Jacq Communications, Inc.
201 citations, 0.1%
|
|
Massachusetts Medical Society
194 citations, 0.1%
|
|
Royal Society of Chemistry (RSC)
189 citations, 0.1%
|
|
180 citations, 0.09%
|
|
American Society of Tropical Medicine and Hygiene
179 citations, 0.09%
|
|
JMIR Publications
177 citations, 0.09%
|
|
SciELO
174 citations, 0.09%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
160 citations, 0.08%
|
|
PAGEPress Publications
156 citations, 0.08%
|
|
American College of Allergy, Asthma, & Immunology
147 citations, 0.08%
|
|
Edizioni Minerva Medica
145 citations, 0.08%
|
|
Sociedade Brasileira de Medicina Tropical
137 citations, 0.07%
|
|
AME Publishing Company
126 citations, 0.07%
|
|
Jaypee Brothers Medical Publishing
124 citations, 0.06%
|
|
F1000 Research
122 citations, 0.06%
|
|
Scientific Research Publishing
119 citations, 0.06%
|
|
117 citations, 0.06%
|
|
Eco-Vector LLC
112 citations, 0.06%
|
|
Science Alert
111 citations, 0.06%
|
|
American Association for Cancer Research (AACR)
109 citations, 0.06%
|
|
IOP Publishing
108 citations, 0.06%
|
|
SLACK
97 citations, 0.05%
|
|
King Faisal Specialist Hospital and Research Centre
96 citations, 0.05%
|
|
Japanese Society of Internal Medicine
92 citations, 0.05%
|
|
American Society of Clinical Oncology (ASCO)
83 citations, 0.04%
|
|
The Japanese Society for Medical Mycology
83 citations, 0.04%
|
|
Microbiology Society
79 citations, 0.04%
|
|
Fundacao Oswaldo Cruz
79 citations, 0.04%
|
|
Asociacion Espanola de Micologia
78 citations, 0.04%
|
|
Medical Journals/Acta D-V
75 citations, 0.04%
|
|
Impact Journals
74 citations, 0.04%
|
|
Centers for Disease Control and Prevention (CDC)
73 citations, 0.04%
|
|
Remedium, Ltd.
72 citations, 0.04%
|
|
Alfmed LLC
68 citations, 0.04%
|
|
American Society of Hematology
67 citations, 0.03%
|
|
American Society for Biochemistry and Molecular Biology
66 citations, 0.03%
|
|
The American Association of Immunologists
66 citations, 0.03%
|
|
American Physiological Society
59 citations, 0.03%
|
|
King Saud University
58 citations, 0.03%
|
|
American Podiatric Medical Association
57 citations, 0.03%
|
|
Annual Reviews
56 citations, 0.03%
|
|
Akshantala Enterprises Private Limited
56 citations, 0.03%
|
|
Research Square Platform LLC
56 citations, 0.03%
|
|
The Endocrine Society
55 citations, 0.03%
|
|
Taehan Uijinkyun Hakhoe
54 citations, 0.03%
|
|
Asociacion Colombiana de Reumatologia
52 citations, 0.03%
|
|
Korean Society for Parasitology
51 citations, 0.03%
|
|
Slovenian Medical Society
51 citations, 0.03%
|
|
Paediatrician Publishers LLC
50 citations, 0.03%
|
|
EDP Sciences
47 citations, 0.02%
|
|
Pharmaceutical Society of Japan
44 citations, 0.02%
|
|
Federation of American Societies for Experimental Biology (FASEB)
44 citations, 0.02%
|
|
PeerJ
43 citations, 0.02%
|
|
Journal of Neurosurgery Publishing Group (JNSPG)
43 citations, 0.02%
|
|
SPIE-Intl Soc Optical Eng
43 citations, 0.02%
|
|
Proceedings of the National Academy of Sciences (PNAS)
41 citations, 0.02%
|
|
Radiological Society of North America (RSNA)
41 citations, 0.02%
|
|
Korean Academy of Medical Sciences
41 citations, 0.02%
|
|
Pleiades Publishing
38 citations, 0.02%
|
|
American Society for Clinical Investigation
38 citations, 0.02%
|
|
IOS Press
37 citations, 0.02%
|
|
Akademiai Kiado
37 citations, 0.02%
|
|
World Scientific
36 citations, 0.02%
|
|
AIP Publishing
36 citations, 0.02%
|
|
Show all (70 more) | |
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
|
Publishing organizations
50
100
150
200
250
300
|
|
Mayo Clinic
251 publications, 1.44%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
187 publications, 1.07%
|
|
University of Miami
149 publications, 0.85%
|
|
Post graduate Institute of Medical Education and Research
142 publications, 0.81%
|
|
Harvard University
129 publications, 0.74%
|
|
University of Pennsylvania
124 publications, 0.71%
|
|
Tel Aviv University
117 publications, 0.67%
|
|
University of Florence
108 publications, 0.62%
|
|
Baylor College of Medicine
94 publications, 0.54%
|
|
University of Toronto
94 publications, 0.54%
|
|
University of Milan
84 publications, 0.48%
|
|
All India Institute of Medical Sciences, Delhi
80 publications, 0.46%
|
|
Wayne State University
79 publications, 0.45%
|
|
New York University
77 publications, 0.44%
|
|
Yonsei University
72 publications, 0.41%
|
|
Thomas Jefferson University
72 publications, 0.41%
|
|
University of Campania "Luigi Vanvitelli"
70 publications, 0.4%
|
|
University of California, San Francisco
66 publications, 0.38%
|
|
Icahn School of Medicine at Mount Sinai
66 publications, 0.38%
|
|
University of California, Irvine
65 publications, 0.37%
|
|
Tehran University of Medical Sciences
64 publications, 0.37%
|
|
Yale University
63 publications, 0.36%
|
|
Cornell University
59 publications, 0.34%
|
|
National and Kapodistrian University of Athens
59 publications, 0.34%
|
|
Tulane University
57 publications, 0.33%
|
|
University of Texas Medical Branch
56 publications, 0.32%
|
|
University of California, Los Angeles
55 publications, 0.32%
|
|
Emory University
54 publications, 0.31%
|
|
Maulana Azad Medical College
52 publications, 0.3%
|
|
Massachusetts General Hospital
52 publications, 0.3%
|
|
Universidade Estadual Paulista
51 publications, 0.29%
|
|
Hadassah Medical Center
50 publications, 0.29%
|
|
University of Naples Federico II
50 publications, 0.29%
|
|
Cairo University
50 publications, 0.29%
|
|
Zagazig University
49 publications, 0.28%
|
|
Rutgers, The State University of New Jersey
48 publications, 0.28%
|
|
Ohio State University
48 publications, 0.28%
|
|
University of Texas Southwestern Medical Center
48 publications, 0.28%
|
|
University of Genoa
47 publications, 0.27%
|
|
University of Bologna
47 publications, 0.27%
|
|
Sheba Medical Center
45 publications, 0.26%
|
|
Universidade Federal do Rio de Janeiro
45 publications, 0.26%
|
|
Catholic University of Korea
45 publications, 0.26%
|
|
Hebrew University of Jerusalem
44 publications, 0.25%
|
|
American University of Beirut Medical Center
44 publications, 0.25%
|
|
University of Minnesota
44 publications, 0.25%
|
|
University of Texas MD Anderson Cancer Center
44 publications, 0.25%
|
|
Mayo Clinic Arizona
44 publications, 0.25%
|
|
University of Cincinnati
44 publications, 0.25%
|
|
Tel Aviv Sourasky Medical Center
43 publications, 0.25%
|
|
University of Illinois at Chicago
43 publications, 0.25%
|
|
New York Medical College
43 publications, 0.25%
|
|
Columbia University
42 publications, 0.24%
|
|
University of Ulsan
41 publications, 0.23%
|
|
Sapienza University of Rome
40 publications, 0.23%
|
|
University of Siena
40 publications, 0.23%
|
|
Mahidol University
40 publications, 0.23%
|
|
University of Louisville
40 publications, 0.23%
|
|
Asan Medical Center
39 publications, 0.22%
|
|
University of Florida
39 publications, 0.22%
|
|
Wake Forest University
39 publications, 0.22%
|
|
Johns Hopkins University
38 publications, 0.22%
|
|
Ben-Gurion University of the Negev
37 publications, 0.21%
|
|
Chinese Academy of Medical Sciences & Peking Union Medical College
37 publications, 0.21%
|
|
University of Copenhagen
37 publications, 0.21%
|
|
Istanbul University Cerrahpasa
36 publications, 0.21%
|
|
Northwestern University
36 publications, 0.21%
|
|
Brigham and Women's Hospital
36 publications, 0.21%
|
|
Ohio State University Wexner Medical Center
35 publications, 0.2%
|
|
Aristotle University of Thessaloniki
35 publications, 0.2%
|
|
Cleveland Clinic
35 publications, 0.2%
|
|
Istanbul University
34 publications, 0.19%
|
|
Rabin Medical Center
34 publications, 0.19%
|
|
University of Southern California
34 publications, 0.19%
|
|
University of Michigan
34 publications, 0.19%
|
|
Ankara University
33 publications, 0.19%
|
|
University College of Medical Sciences
33 publications, 0.19%
|
|
Lady Hardinge Medical College
33 publications, 0.19%
|
|
Stanford University
33 publications, 0.19%
|
|
Fukushima Medical University
33 publications, 0.19%
|
|
Technion – Israel Institute of Technology
32 publications, 0.18%
|
|
Soroka Medical Center
32 publications, 0.18%
|
|
Helsinki University Hospital
32 publications, 0.18%
|
|
King Saud University
31 publications, 0.18%
|
|
Chung-Ang University
31 publications, 0.18%
|
|
New York University Langone Health
31 publications, 0.18%
|
|
University of Buenos Aires
31 publications, 0.18%
|
|
Memorial Sloan Kettering Cancer Center
31 publications, 0.18%
|
|
Sunnybrook Health Sciences Centre
31 publications, 0.18%
|
|
Guru Teg Bahadur Hospital
30 publications, 0.17%
|
|
Sungkyunkwan University
30 publications, 0.17%
|
|
Mayo Clinic in Florida
30 publications, 0.17%
|
|
University of Texas Health Science Center at Houston
30 publications, 0.17%
|
|
Beth Israel Deaconess Medical Center
30 publications, 0.17%
|
|
Hacettepe University
29 publications, 0.17%
|
|
Chang Gung University
29 publications, 0.17%
|
|
University of North Carolina at Chapel Hill
29 publications, 0.17%
|
|
Jawaharlal Institute of Postgraduate Medical Education and Research
28 publications, 0.16%
|
|
University of British Columbia
28 publications, 0.16%
|
|
Drexel University
27 publications, 0.15%
|
|
Show all (70 more) | |
50
100
150
200
250
300
|
Publishing organizations in 5 years
20
40
60
80
100
120
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
102 publications, 3.63%
|
|
Mayo Clinic
82 publications, 2.92%
|
|
Post graduate Institute of Medical Education and Research
41 publications, 1.46%
|
|
Harvard University
41 publications, 1.46%
|
|
University of Miami
40 publications, 1.42%
|
|
Yale University
36 publications, 1.28%
|
|
Universidade Estadual Paulista
34 publications, 1.21%
|
|
Ohio State University
33 publications, 1.17%
|
|
Wayne State University
33 publications, 1.17%
|
|
University of Milan
31 publications, 1.1%
|
|
University of Bologna
28 publications, 1%
|
|
Brigham and Women's Hospital
27 publications, 0.96%
|
|
University of Toronto
27 publications, 0.96%
|
|
Cornell University
26 publications, 0.92%
|
|
Ohio State University Wexner Medical Center
26 publications, 0.92%
|
|
University of Pennsylvania
25 publications, 0.89%
|
|
All India Institute of Medical Sciences, Delhi
24 publications, 0.85%
|
|
New York University
23 publications, 0.82%
|
|
Sapienza University of Rome
20 publications, 0.71%
|
|
University of Illinois at Chicago
20 publications, 0.71%
|
|
University of California, Los Angeles
20 publications, 0.71%
|
|
University of Campania "Luigi Vanvitelli"
19 publications, 0.68%
|
|
University of California, Irvine
19 publications, 0.68%
|
|
University of Naples Federico II
18 publications, 0.64%
|
|
University of Southern California
18 publications, 0.64%
|
|
Rutgers, The State University of New Jersey
18 publications, 0.64%
|
|
University of Texas Southwestern Medical Center
18 publications, 0.64%
|
|
Mayo Clinic Arizona
18 publications, 0.64%
|
|
Chinese Academy of Medical Sciences & Peking Union Medical College
17 publications, 0.6%
|
|
Mayo Clinic in Florida
17 publications, 0.6%
|
|
Tehran University of Medical Sciences
16 publications, 0.57%
|
|
Università Cattolica del Sacro Cuore
16 publications, 0.57%
|
|
Cairo University
16 publications, 0.57%
|
|
Massachusetts General Hospital
16 publications, 0.57%
|
|
University of California, San Francisco
16 publications, 0.57%
|
|
University of Szeged
15 publications, 0.53%
|
|
Albert Einstein College of Medicine
15 publications, 0.53%
|
|
Icahn School of Medicine at Mount Sinai
15 publications, 0.53%
|
|
University of Minnesota
15 publications, 0.53%
|
|
Wake Forest University
15 publications, 0.53%
|
|
Texas A&M University Health Science Center
15 publications, 0.53%
|
|
All India Institute of Medical Sciences, Jodhpur
14 publications, 0.5%
|
|
Johns Hopkins University
14 publications, 0.5%
|
|
University of Florence
14 publications, 0.5%
|
|
Northwestern University
14 publications, 0.5%
|
|
University of Arizona
14 publications, 0.5%
|
|
Tel Aviv University
13 publications, 0.46%
|
|
Autonomous University of Barcelona
13 publications, 0.46%
|
|
University of Turin
13 publications, 0.46%
|
|
University of Modena and Reggio Emilia
13 publications, 0.46%
|
|
Fukushima Medical University
13 publications, 0.46%
|
|
Zhejiang University
12 publications, 0.43%
|
|
American University of Beirut Medical Center
12 publications, 0.43%
|
|
Saint Joseph University
12 publications, 0.43%
|
|
University of Siena
12 publications, 0.43%
|
|
Baylor College of Medicine
12 publications, 0.43%
|
|
Baylor University Medical Center
12 publications, 0.43%
|
|
Women's College Hospital
12 publications, 0.43%
|
|
University of Sydney
11 publications, 0.39%
|
|
Vita-Salute San Raffaele University
11 publications, 0.39%
|
|
University of Queensland
11 publications, 0.39%
|
|
University of KwaZulu-Natal
11 publications, 0.39%
|
|
Case Western Reserve University
11 publications, 0.39%
|
|
Aristotle University of Thessaloniki
11 publications, 0.39%
|
|
University of Valencia
11 publications, 0.39%
|
|
Hospital Clínic de Barcelona
11 publications, 0.39%
|
|
University of Florida
11 publications, 0.39%
|
|
Reina Sofia Hospital
11 publications, 0.39%
|
|
University of Cincinnati
11 publications, 0.39%
|
|
Tunis El Manar University
11 publications, 0.39%
|
|
Ben-Gurion University of the Negev
10 publications, 0.36%
|
|
Peking Union Medical College Hospital
10 publications, 0.36%
|
|
University of Brescia
10 publications, 0.36%
|
|
Pennsylvania State University
10 publications, 0.36%
|
|
University of Washington
10 publications, 0.36%
|
|
Oakland University
10 publications, 0.36%
|
|
Brown University
10 publications, 0.36%
|
|
University of Ottawa
10 publications, 0.36%
|
|
Creighton University
10 publications, 0.36%
|
|
Peking University
9 publications, 0.32%
|
|
Fudan University
9 publications, 0.32%
|
|
University of Lisbon
9 publications, 0.32%
|
|
University of Southern Denmark
9 publications, 0.32%
|
|
University of Trieste
9 publications, 0.32%
|
|
Tulane University
9 publications, 0.32%
|
|
University Medical Center of the Johannes Gutenberg University Mainz
9 publications, 0.32%
|
|
Osaka Metropolitan University
9 publications, 0.32%
|
|
University of Texas MD Anderson Cancer Center
9 publications, 0.32%
|
|
Wrocław Medical University
9 publications, 0.32%
|
|
University of Barcelona
9 publications, 0.32%
|
|
University of North Carolina at Chapel Hill
9 publications, 0.32%
|
|
University of Nebraska Medical Center
9 publications, 0.32%
|
|
Koc University
8 publications, 0.28%
|
|
Ankara University
8 publications, 0.28%
|
|
All India Institute of Medical Sciences, Bhubaneswar
8 publications, 0.28%
|
|
University of Health Sciences, Turkey
8 publications, 0.28%
|
|
Atal Bihari Vajpayee Indian Institute of Information Technology and Management
8 publications, 0.28%
|
|
Sichuan University
8 publications, 0.28%
|
|
Xiangya Hospital Central South University
8 publications, 0.28%
|
|
Humanitas University
8 publications, 0.28%
|
|
Show all (70 more) | |
20
40
60
80
100
120
|
Publishing countries
500
1000
1500
2000
2500
3000
3500
4000
4500
|
|
USA
|
USA, 4026, 23.07%
USA
4026 publications, 23.07%
|
India
|
India, 1083, 6.21%
India
1083 publications, 6.21%
|
Italy
|
Italy, 911, 5.22%
Italy
911 publications, 5.22%
|
Japan
|
Japan, 699, 4.01%
Japan
699 publications, 4.01%
|
Spain
|
Spain, 692, 3.97%
Spain
692 publications, 3.97%
|
China
|
China, 597, 3.42%
China
597 publications, 3.42%
|
Turkey
|
Turkey, 589, 3.38%
Turkey
589 publications, 3.38%
|
Brazil
|
Brazil, 532, 3.05%
Brazil
532 publications, 3.05%
|
United Kingdom
|
United Kingdom, 423, 2.42%
United Kingdom
423 publications, 2.42%
|
Republic of Korea
|
Republic of Korea, 383, 2.2%
Republic of Korea
383 publications, 2.2%
|
Israel
|
Israel, 325, 1.86%
Israel
325 publications, 1.86%
|
Germany
|
Germany, 317, 1.82%
Germany
317 publications, 1.82%
|
Canada
|
Canada, 280, 1.6%
Canada
280 publications, 1.6%
|
France
|
France, 268, 1.54%
France
268 publications, 1.54%
|
Mexico
|
Mexico, 264, 1.51%
Mexico
264 publications, 1.51%
|
Egypt
|
Egypt, 224, 1.28%
Egypt
224 publications, 1.28%
|
Australia
|
Australia, 211, 1.21%
Australia
211 publications, 1.21%
|
Iran
|
Iran, 205, 1.17%
Iran
205 publications, 1.17%
|
Greece
|
Greece, 171, 0.98%
Greece
171 publications, 0.98%
|
Netherlands
|
Netherlands, 153, 0.88%
Netherlands
153 publications, 0.88%
|
Singapore
|
Singapore, 148, 0.85%
Singapore
148 publications, 0.85%
|
Poland
|
Poland, 139, 0.8%
Poland
139 publications, 0.8%
|
Saudi Arabia
|
Saudi Arabia, 137, 0.79%
Saudi Arabia
137 publications, 0.79%
|
Portugal
|
Portugal, 116, 0.66%
Portugal
116 publications, 0.66%
|
Nigeria
|
Nigeria, 109, 0.62%
Nigeria
109 publications, 0.62%
|
Argentina
|
Argentina, 107, 0.61%
Argentina
107 publications, 0.61%
|
Denmark
|
Denmark, 104, 0.6%
Denmark
104 publications, 0.6%
|
Thailand
|
Thailand, 102, 0.58%
Thailand
102 publications, 0.58%
|
Tunisia
|
Tunisia, 95, 0.54%
Tunisia
95 publications, 0.54%
|
South Africa
|
South Africa, 95, 0.54%
South Africa
95 publications, 0.54%
|
Belgium
|
Belgium, 93, 0.53%
Belgium
93 publications, 0.53%
|
Venezuela
|
Venezuela, 92, 0.53%
Venezuela
92 publications, 0.53%
|
Lebanon
|
Lebanon, 88, 0.5%
Lebanon
88 publications, 0.5%
|
Switzerland
|
Switzerland, 84, 0.48%
Switzerland
84 publications, 0.48%
|
Austria
|
Austria, 72, 0.41%
Austria
72 publications, 0.41%
|
Colombia
|
Colombia, 61, 0.35%
Colombia
61 publications, 0.35%
|
Finland
|
Finland, 52, 0.3%
Finland
52 publications, 0.3%
|
Sweden
|
Sweden, 51, 0.29%
Sweden
51 publications, 0.29%
|
Malaysia
|
Malaysia, 49, 0.28%
Malaysia
49 publications, 0.28%
|
UAE
|
UAE, 48, 0.28%
UAE
48 publications, 0.28%
|
Hungary
|
Hungary, 46, 0.26%
Hungary
46 publications, 0.26%
|
Chile
|
Chile, 46, 0.26%
Chile
46 publications, 0.26%
|
Ireland
|
Ireland, 43, 0.25%
Ireland
43 publications, 0.25%
|
Philippines
|
Philippines, 42, 0.24%
Philippines
42 publications, 0.24%
|
Pakistan
|
Pakistan, 41, 0.23%
Pakistan
41 publications, 0.23%
|
Bulgaria
|
Bulgaria, 35, 0.2%
Bulgaria
35 publications, 0.2%
|
Puerto Rico
|
Puerto Rico, 31, 0.18%
Puerto Rico
31 publications, 0.18%
|
Czech Republic
|
Czech Republic, 31, 0.18%
Czech Republic
31 publications, 0.18%
|
Russia
|
Russia, 27, 0.15%
Russia
27 publications, 0.15%
|
Romania
|
Romania, 27, 0.15%
Romania
27 publications, 0.15%
|
Croatia
|
Croatia, 26, 0.15%
Croatia
26 publications, 0.15%
|
Nepal
|
Nepal, 25, 0.14%
Nepal
25 publications, 0.14%
|
Kuwait
|
Kuwait, 24, 0.14%
Kuwait
24 publications, 0.14%
|
Indonesia
|
Indonesia, 23, 0.13%
Indonesia
23 publications, 0.13%
|
Morocco
|
Morocco, 23, 0.13%
Morocco
23 publications, 0.13%
|
Peru
|
Peru, 23, 0.13%
Peru
23 publications, 0.13%
|
Sri Lanka
|
Sri Lanka, 21, 0.12%
Sri Lanka
21 publications, 0.12%
|
Jordan
|
Jordan, 20, 0.11%
Jordan
20 publications, 0.11%
|
Serbia
|
Serbia, 19, 0.11%
Serbia
19 publications, 0.11%
|
Ethiopia
|
Ethiopia, 19, 0.11%
Ethiopia
19 publications, 0.11%
|
Uruguay
|
Uruguay, 17, 0.1%
Uruguay
17 publications, 0.1%
|
Guatemala
|
Guatemala, 16, 0.09%
Guatemala
16 publications, 0.09%
|
Norway
|
Norway, 16, 0.09%
Norway
16 publications, 0.09%
|
Yemen
|
Yemen, 14, 0.08%
Yemen
14 publications, 0.08%
|
New Zealand
|
New Zealand, 14, 0.08%
New Zealand
14 publications, 0.08%
|
Senegal
|
Senegal, 14, 0.08%
Senegal
14 publications, 0.08%
|
Ecuador
|
Ecuador, 14, 0.08%
Ecuador
14 publications, 0.08%
|
Iraq
|
Iraq, 13, 0.07%
Iraq
13 publications, 0.07%
|
Libya
|
Libya, 12, 0.07%
Libya
12 publications, 0.07%
|
El Salvador
|
El Salvador, 12, 0.07%
El Salvador
12 publications, 0.07%
|
Mali
|
Mali, 11, 0.06%
Mali
11 publications, 0.06%
|
Malta
|
Malta, 11, 0.06%
Malta
11 publications, 0.06%
|
Slovenia
|
Slovenia, 11, 0.06%
Slovenia
11 publications, 0.06%
|
Ukraine
|
Ukraine, 10, 0.06%
Ukraine
10 publications, 0.06%
|
Bangladesh
|
Bangladesh, 10, 0.06%
Bangladesh
10 publications, 0.06%
|
Togo
|
Togo, 10, 0.06%
Togo
10 publications, 0.06%
|
Benin
|
Benin, 9, 0.05%
Benin
9 publications, 0.05%
|
Burkina Faso
|
Burkina Faso, 9, 0.05%
Burkina Faso
9 publications, 0.05%
|
Vietnam
|
Vietnam, 9, 0.05%
Vietnam
9 publications, 0.05%
|
Qatar
|
Qatar, 9, 0.05%
Qatar
9 publications, 0.05%
|
Slovakia
|
Slovakia, 9, 0.05%
Slovakia
9 publications, 0.05%
|
Tanzania
|
Tanzania, 9, 0.05%
Tanzania
9 publications, 0.05%
|
Uganda
|
Uganda, 9, 0.05%
Uganda
9 publications, 0.05%
|
French Guiana
|
French Guiana, 9, 0.05%
French Guiana
9 publications, 0.05%
|
Honduras
|
Honduras, 8, 0.05%
Honduras
8 publications, 0.05%
|
Yugoslavia
|
Yugoslavia, 8, 0.05%
Yugoslavia
8 publications, 0.05%
|
Iceland
|
Iceland, 7, 0.04%
Iceland
7 publications, 0.04%
|
Côte d'Ivoire
|
Côte d'Ivoire, 7, 0.04%
Côte d'Ivoire
7 publications, 0.04%
|
Malawi
|
Malawi, 7, 0.04%
Malawi
7 publications, 0.04%
|
Oman
|
Oman, 7, 0.04%
Oman
7 publications, 0.04%
|
Panama
|
Panama, 7, 0.04%
Panama
7 publications, 0.04%
|
Ghana
|
Ghana, 6, 0.03%
Ghana
6 publications, 0.03%
|
Guinea
|
Guinea, 6, 0.03%
Guinea
6 publications, 0.03%
|
Cameroon
|
Cameroon, 6, 0.03%
Cameroon
6 publications, 0.03%
|
Democratic Republic of the Congo
|
Democratic Republic of the Congo, 6, 0.03%
Democratic Republic of the Congo
6 publications, 0.03%
|
Rwanda
|
Rwanda, 6, 0.03%
Rwanda
6 publications, 0.03%
|
Syria
|
Syria, 6, 0.03%
Syria
6 publications, 0.03%
|
USSR
|
USSR, 6, 0.03%
USSR
6 publications, 0.03%
|
Bahrain
|
Bahrain, 5, 0.03%
Bahrain
5 publications, 0.03%
|
Botswana
|
Botswana, 5, 0.03%
Botswana
5 publications, 0.03%
|
Show all (70 more) | |
500
1000
1500
2000
2500
3000
3500
4000
4500
|
Publishing countries in 5 years
100
200
300
400
500
600
700
800
|
|
USA
|
USA, 797, 28.33%
USA
797 publications, 28.33%
|
Italy
|
Italy, 264, 9.38%
Italy
264 publications, 9.38%
|
India
|
India, 230, 8.18%
India
230 publications, 8.18%
|
Spain
|
Spain, 222, 7.89%
Spain
222 publications, 7.89%
|
China
|
China, 194, 6.9%
China
194 publications, 6.9%
|
Brazil
|
Brazil, 147, 5.23%
Brazil
147 publications, 5.23%
|
Japan
|
Japan, 116, 4.12%
Japan
116 publications, 4.12%
|
Turkey
|
Turkey, 87, 3.09%
Turkey
87 publications, 3.09%
|
Germany
|
Germany, 74, 2.63%
Germany
74 publications, 2.63%
|
United Kingdom
|
United Kingdom, 70, 2.49%
United Kingdom
70 publications, 2.49%
|
France
|
France, 62, 2.2%
France
62 publications, 2.2%
|
Canada
|
Canada, 62, 2.2%
Canada
62 publications, 2.2%
|
Australia
|
Australia, 56, 1.99%
Australia
56 publications, 1.99%
|
Egypt
|
Egypt, 51, 1.81%
Egypt
51 publications, 1.81%
|
Mexico
|
Mexico, 50, 1.78%
Mexico
50 publications, 1.78%
|
Portugal
|
Portugal, 38, 1.35%
Portugal
38 publications, 1.35%
|
Poland
|
Poland, 34, 1.21%
Poland
34 publications, 1.21%
|
Greece
|
Greece, 33, 1.17%
Greece
33 publications, 1.17%
|
Israel
|
Israel, 33, 1.17%
Israel
33 publications, 1.17%
|
Republic of Korea
|
Republic of Korea, 33, 1.17%
Republic of Korea
33 publications, 1.17%
|
Singapore
|
Singapore, 32, 1.14%
Singapore
32 publications, 1.14%
|
Iran
|
Iran, 30, 1.07%
Iran
30 publications, 1.07%
|
Lebanon
|
Lebanon, 30, 1.07%
Lebanon
30 publications, 1.07%
|
Denmark
|
Denmark, 26, 0.92%
Denmark
26 publications, 0.92%
|
Switzerland
|
Switzerland, 26, 0.92%
Switzerland
26 publications, 0.92%
|
Hungary
|
Hungary, 25, 0.89%
Hungary
25 publications, 0.89%
|
Tunisia
|
Tunisia, 25, 0.89%
Tunisia
25 publications, 0.89%
|
Netherlands
|
Netherlands, 19, 0.68%
Netherlands
19 publications, 0.68%
|
Colombia
|
Colombia, 18, 0.64%
Colombia
18 publications, 0.64%
|
South Africa
|
South Africa, 17, 0.6%
South Africa
17 publications, 0.6%
|
Saudi Arabia
|
Saudi Arabia, 16, 0.57%
Saudi Arabia
16 publications, 0.57%
|
Chile
|
Chile, 16, 0.57%
Chile
16 publications, 0.57%
|
Argentina
|
Argentina, 15, 0.53%
Argentina
15 publications, 0.53%
|
Belgium
|
Belgium, 15, 0.53%
Belgium
15 publications, 0.53%
|
Thailand
|
Thailand, 13, 0.46%
Thailand
13 publications, 0.46%
|
Philippines
|
Philippines, 13, 0.46%
Philippines
13 publications, 0.46%
|
Ireland
|
Ireland, 12, 0.43%
Ireland
12 publications, 0.43%
|
Morocco
|
Morocco, 12, 0.43%
Morocco
12 publications, 0.43%
|
Russia
|
Russia, 11, 0.39%
Russia
11 publications, 0.39%
|
Austria
|
Austria, 10, 0.36%
Austria
10 publications, 0.36%
|
UAE
|
UAE, 9, 0.32%
UAE
9 publications, 0.32%
|
Croatia
|
Croatia, 9, 0.32%
Croatia
9 publications, 0.32%
|
Indonesia
|
Indonesia, 8, 0.28%
Indonesia
8 publications, 0.28%
|
Malaysia
|
Malaysia, 8, 0.28%
Malaysia
8 publications, 0.28%
|
Romania
|
Romania, 8, 0.28%
Romania
8 publications, 0.28%
|
Vietnam
|
Vietnam, 7, 0.25%
Vietnam
7 publications, 0.25%
|
Malta
|
Malta, 7, 0.25%
Malta
7 publications, 0.25%
|
Nepal
|
Nepal, 7, 0.25%
Nepal
7 publications, 0.25%
|
Sweden
|
Sweden, 7, 0.25%
Sweden
7 publications, 0.25%
|
Finland
|
Finland, 6, 0.21%
Finland
6 publications, 0.21%
|
French Guiana
|
French Guiana, 6, 0.21%
French Guiana
6 publications, 0.21%
|
Bulgaria
|
Bulgaria, 5, 0.18%
Bulgaria
5 publications, 0.18%
|
Ukraine
|
Ukraine, 4, 0.14%
Ukraine
4 publications, 0.14%
|
Yemen
|
Yemen, 4, 0.14%
Yemen
4 publications, 0.14%
|
Qatar
|
Qatar, 4, 0.14%
Qatar
4 publications, 0.14%
|
Cyprus
|
Cyprus, 4, 0.14%
Cyprus
4 publications, 0.14%
|
Nigeria
|
Nigeria, 4, 0.14%
Nigeria
4 publications, 0.14%
|
New Zealand
|
New Zealand, 4, 0.14%
New Zealand
4 publications, 0.14%
|
Ethiopia
|
Ethiopia, 4, 0.14%
Ethiopia
4 publications, 0.14%
|
Bangladesh
|
Bangladesh, 3, 0.11%
Bangladesh
3 publications, 0.11%
|
Cameroon
|
Cameroon, 3, 0.11%
Cameroon
3 publications, 0.11%
|
Pakistan
|
Pakistan, 3, 0.11%
Pakistan
3 publications, 0.11%
|
Peru
|
Peru, 3, 0.11%
Peru
3 publications, 0.11%
|
Puerto Rico
|
Puerto Rico, 3, 0.11%
Puerto Rico
3 publications, 0.11%
|
Serbia
|
Serbia, 3, 0.11%
Serbia
3 publications, 0.11%
|
Tanzania
|
Tanzania, 3, 0.11%
Tanzania
3 publications, 0.11%
|
Sri Lanka
|
Sri Lanka, 3, 0.11%
Sri Lanka
3 publications, 0.11%
|
Afghanistan
|
Afghanistan, 2, 0.07%
Afghanistan
2 publications, 0.07%
|
Venezuela
|
Venezuela, 2, 0.07%
Venezuela
2 publications, 0.07%
|
Guinea
|
Guinea, 2, 0.07%
Guinea
2 publications, 0.07%
|
Jordan
|
Jordan, 2, 0.07%
Jordan
2 publications, 0.07%
|
Iraq
|
Iraq, 2, 0.07%
Iraq
2 publications, 0.07%
|
Democratic Republic of the Congo
|
Democratic Republic of the Congo, 2, 0.07%
Democratic Republic of the Congo
2 publications, 0.07%
|
Kuwait
|
Kuwait, 2, 0.07%
Kuwait
2 publications, 0.07%
|
Norway
|
Norway, 2, 0.07%
Norway
2 publications, 0.07%
|
Oman
|
Oman, 2, 0.07%
Oman
2 publications, 0.07%
|
Slovenia
|
Slovenia, 2, 0.07%
Slovenia
2 publications, 0.07%
|
Togo
|
Togo, 2, 0.07%
Togo
2 publications, 0.07%
|
Czech Republic
|
Czech Republic, 2, 0.07%
Czech Republic
2 publications, 0.07%
|
Belarus
|
Belarus, 1, 0.04%
Belarus
1 publication, 0.04%
|
Albania
|
Albania, 1, 0.04%
Albania
1 publication, 0.04%
|
Algeria
|
Algeria, 1, 0.04%
Algeria
1 publication, 0.04%
|
Bahrain
|
Bahrain, 1, 0.04%
Bahrain
1 publication, 0.04%
|
Botswana
|
Botswana, 1, 0.04%
Botswana
1 publication, 0.04%
|
Burkina Faso
|
Burkina Faso, 1, 0.04%
Burkina Faso
1 publication, 0.04%
|
Haiti
|
Haiti, 1, 0.04%
Haiti
1 publication, 0.04%
|
Gambia
|
Gambia, 1, 0.04%
Gambia
1 publication, 0.04%
|
Guadeloupe
|
Guadeloupe, 1, 0.04%
Guadeloupe
1 publication, 0.04%
|
Guinea-Bissau
|
Guinea-Bissau, 1, 0.04%
Guinea-Bissau
1 publication, 0.04%
|
Honduras
|
Honduras, 1, 0.04%
Honduras
1 publication, 0.04%
|
Georgia
|
Georgia, 1, 0.04%
Georgia
1 publication, 0.04%
|
Dominica
|
Dominica, 1, 0.04%
Dominica
1 publication, 0.04%
|
Kenya
|
Kenya, 1, 0.04%
Kenya
1 publication, 0.04%
|
Costa Rica
|
Costa Rica, 1, 0.04%
Costa Rica
1 publication, 0.04%
|
Côte d'Ivoire
|
Côte d'Ivoire, 1, 0.04%
Côte d'Ivoire
1 publication, 0.04%
|
Latvia
|
Latvia, 1, 0.04%
Latvia
1 publication, 0.04%
|
Mauritania
|
Mauritania, 1, 0.04%
Mauritania
1 publication, 0.04%
|
Madagascar
|
Madagascar, 1, 0.04%
Madagascar
1 publication, 0.04%
|
Malawi
|
Malawi, 1, 0.04%
Malawi
1 publication, 0.04%
|
Mali
|
Mali, 1, 0.04%
Mali
1 publication, 0.04%
|
Show all (70 more) | |
100
200
300
400
500
600
700
800
|
2 profile journal articles
Luís Flávio
65 publications,
640 citations
h-index: 16
1 profile journal article
Duarte Maria Irma Seixas
154 publications,
2 590 citations
h-index: 29
1 profile journal article
Sulejmani Pranvera
4 publications,
6 citations
h-index: 1
1 profile journal article
Danielle Marie
🥼
34 publications,
312 citations
h-index: 9